Showing results (401-410 of 1,393) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|September 2, 2025
Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibition in Patients With Metastatic Pancreatic CancerRishi Surana, Micaela Morgado, Ashwin Somasundaram, et al.
JCO Precision Oncology|July 28, 2018
Rucaparib Monotherapy in Patients With Pancreatic Cancer and a Known Deleterious BRCA MutationRachna T Shroff, Andrew Hendifar, Robert R McWilliams, et al.
JCO Precision Oncology|August 9, 2018
Transcriptional subtyping and CD8 immunohistochemistry identifies poor prognosis stage II/III colorectal cancer patients who benefit from adjuvant chemotherapyW L Allen, P D Dunne, S McDade, et al.
JCO Precision Oncology|July 24, 2018
Survival Outcomes by TP53 Mutation Status in Metastatic Breast CancerFunda Meric-Bernstam, Xiaofeng Zheng, Maryam Shariati, et al.
JCO Precision Oncology|July 14, 2018
Personalized Medicine in the Oncology Clinic: Implementation and Outcomes of the Johns Hopkins Molecular Tumor BoardW Brian Dalton, Patrick M Forde, Hyunseok Kang, et al.
JCO Precision Oncology|June 5, 2018
Accurate RNA Sequencing From Formalin-Fixed Cancer Tissue To Represent High-Quality Transcriptome From Frozen TissueJialu Li, Chunxiao Fu, Terence P Speed, et al.
JCO Precision Oncology|June 29, 2018
Identifying a Clinically Applicable Mutational Burden Threshold as a Potential Biomarker of Response to Immune Checkpoint Therapy in Solid TumorsAnshuman Panda, Anil Betigeri, Kalyanasundaram Subramanian, et al.
JCO Precision Oncology|July 7, 2017
Next Generation Sequencing Reveals Potentially Actionable Alterations in the Majority of Patients with Lymphoid MalignanciesAaron M Goodman, Michael Choi, Matthew Wieduwilt, et al.
JCO Precision Oncology|September 11, 2020
PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic MelanomaFederica Catalanotti, Donavan T Cheng, Alexander N Shoushtari, et al.
JCO Precision Oncology|September 11, 2020
Participant Attitudes Toward an Intensive Trial of Multiple Biopsies, Multidimensional Molecular Analysis, and Reporting of Results in Metastatic Triple-Negative Breast CancerNicole M Kuderer, Kimberly A Burton, Sibel Blau, et al.
Pageof 140